Legislation

To read the full text, visit the Federal Register of Legislation.

This Instrument amends TGO 110 to introduce minimum safety and quality requirements for therapeutic vaping substances and related goods, and to restrict the available flavours of therapeutic vaping substances and substance accessories.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

This Therapeutic Goods Order constitutes a standard for therapeutic vaping substances, therapeutic vaping substance accessories, therapeutic vaping kits and goods in a therapeutic vaping pack.

This Therapeutic Goods Order sets out general and specific requirements relating to all biologicals, human musculoskeletal tissue products, human cardiovascular tissue products, human ocular tissue products, human skin products and human amnion products.

This Specification facilitates the release of specified therapeutic goods information held by the TGA in the database known as the System for Australian Recall Actions (SARA), relating to recall actions involving therapeutic goods.

This Instrument amends the Therapeutic Goods Advertising Code to include a reference to the Therapeutic Goods (Restricted Representations—COVID-19 Vaccines) Permission 2022.

This Instrument contains the Therapeutic Goods Advertising Code. The Code specifies a range of requirements to protect the Australian public from the personal and public health risks associated with unethical, inaccurate or misleading advertising practices relating to the advertising of therapeutic goods.

This Specification facilitates the public release of therapeutic goods information that has been provided to the TGA by a sponsor in an Online Notification Form that relates to the transition of a medical device from certain European Directives to the new EU medical devices regulation.

This Determination specifies the kinds of vaping goods which may be supplied or possessed by specified persons or classes of persons and under what circumstances or conditions.

To read the full text, visit the Federal Register of Legislation.

The Therapeutic Goods Act 1989 provides for the establishment and maintenance of a national system of controls relating to the quality, safety, efficacy and timely availability of therapeutic goods that are used in Australia or exported from Australia.

The Act amends the Therapeutic Goods Act 1989 to improve regulation of therapeutic goods in Australia, enhancing safety and efficacy standards.

The Act amends the Therapeutic Goods Act 1989 to improve regulation of therapeutic goods in Australia, enhancing safety and efficacy standards.

This Act amends the Therapeutic Goods Act 1989 to improve regulation of therapeutic goods in Australia, enhancing safety and access.

This legislation aims to streamline and improve the regulation of therapeutic goods in Australia by updating parts of the Therapeutic Goods Act 1989.

This Act removed the Health Minister's approval requirement for RU486 (abortion medication), transferring decision-making authority to the Therapeutic Goods Administration.

This Instrument amends the Therapeutic Goods Advertising Code to add a reference to the Therapeutic Goods (Restricted Representations—HHD Group Pty Limited) (AZ) Permission 2021.

This Instrument makes various amendments to the Therapeutic Goods Advertising Code.

The Act amends the Therapeutic Goods Act 1989 to improve regulation of therapeutic goods in Australia, enhancing safety and efficacy standards.

This Specification facilitates the public release of specified therapeutic goods information relating to exemptions that do or do not apply under the Annual Charges Exemption Scheme.

This Specification facilitates the release of information about the materials used in the production of specified medical devices to specified persons for certain purposes.

This Specification facilitates the release of specified therapeutic goods information, relating to in-house in vitro diagnostic (IVD) medical devices, to the National Association of Testing Authorities (NATA).